Cancer-prevention vaccine for Lynch syndrome patients under research in Houston

Researchers in Houston are testing a vaccine designed to protect people with Lynch syndrome from colorectal cancer and other malignancies. The vaccine aims to train the immune system to recognise and destroy cancerous cells. People with Lynch syndrome are at particularly high risk of developing several types of cancer.